Log In
BCIQ
Print this Print this
 

dactinomycin lipid nanoparticle

  Manage Alerts
Collapse Summary General Information
Company NanoSmart Pharmaceuticals Inc.
DescriptionAntinuclear antibody (ANA) conjugated to lipid nanoparticle containing dactinomycin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSarcoma
Indication DetailsTreat Ewing's sarcoma
Regulatory Designation U.S. - Orphan Drug (Treat Ewing's sarcoma)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today